Legal Opinion
Sanofi-Synthelabo v. Apotex Inc.
District Court, S.D. New York
Decided August 31, 2006No. 02 Civ. 2255(SHS)PublishedCited by 18 opinions
1Opinion of the Court
OPINION
STEIN, District Judge.
[[Image here]]
[[Image here]]
I. OVERVIEW
Plavix, the most widely prescribed prescription blood-thinning agent in the world, prevents platelets in blood from aggregating around obstructions — such as metal stents or cholesterol deposits — in arterial passageways. Forty-eight million Americans take Plavix daily to prevent potentially fatal blood clots. This action arose between Sanofi-Aventis, Sanofi-Syn-thelabo, Inc. and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, “Sanofi”) — those entities that invested in the research and…
2Cases cited50 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- MARKMAN Et Al. v. WESTVIEW INSTRUMENTS, INC., Et Al.Supreme Court of the United States · 1996
- Herbert Markman and Positek, Inc. v. Westview Instruments, Inc. And Althon Enterprises, Inc.Court of Appeals for the Federal Circuit · 1995
- University of Texas v. CamenischSupreme Court of the United States · 1981
- Koster v. (American) Lumbermens Mutual Casualty Co.Supreme Court of the United States · 1947
45 more not listed; retrieve them via the Exa API.
3Cited by18 opinions
- Sanofi-Synthelabo v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2006
- Sanofi-Synthelabo v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2008
- Sanofi-Aventis v. Apotex Inc.Court of Appeals for the Federal Circuit · 2011
- Viropharma Incorporated v. HamburgDistrict Court, District of Columbia · 2012
- Sanofi-Synthelabo v. Apotex Inc.District Court, S.D. New York · 2007
13 more not listed; retrieve them via the Exa API.